Literature DB >> 8510765

Evidence for uptake2-mediated O-methylation of noradrenaline in the human amnion FL cell-line.

V Marino1, I S de la Lande, M Newlyn, D A Parker.   

Abstract

The uptake and metabolism of 3H-noradrenaline has been examined in the FL cell-line derived originally from human amnion. Cell cultures metabolised 3H-noradrenaline (1.0 mumol/l) to 3H-normetanephrine and, to a lesser extent, to metabolites (not distinguished) of the O-methylated deaminated fraction; primary deaminated metabolites were not detected. 3H-normetanephrine formation a) was not saturable in the noradrenaline concentration range 0.2-150 mumol/l, b) was decreased to 20%-30% of control levels by uptake2 inhibitors (O-methylisoprenaline, 20 and 100 mumol/l; cimetidine, 10 mumol/l; hydrocortisone, 200 mumol/l) and c), was almost insensitive to uptake1 inhibitors (cocaine, 30 mumol/l; desipramine, 3 mumol/l). Uptake of noradrenaline was manifested after 30 minutes as a 6-fold increase in the cell content of the amine following inhibition of catechol-O-methyl transferase, either alone or in conjunction with inhibition of monoamine oxidase. Uptake was decreased maximally to 40% of control levels by O-methylisoprenaline. IC50 values for inhibition of the O-methylisoprenaline-sensitive component of uptake were (in mumol/l): corticosterone (0.3), papaverine (1.1), O-methylisoprenaline (3.0), cimetidine (6.0), (-)noradrenaline (460), and tetraethylammonium (2230). Except for the last agent, for which a comparative value is not available, the IC50's are in good agreement with those for inhibition of uptake2 in the Caki-1 cell-line reported by other investigators. The component of uptake resistant to O-methylisoprenaline was depressed by papaverine (a 50% decrease at 50 mumol/l), but was not affected by the other uptake2 inhibitors or by cocaine (30 mumol/l).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510765     DOI: 10.1007/BF00165386

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Distribution of extraneuronal uptake1 in reproductive tissues: studies on cells in culture.

Authors:  I S de la Lande; V Marino; T Lavranos; J A Kennedy; D A Parker; R F Seamark
Journal:  J Neural Transm Suppl       Date:  1991

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Fate of noradrenaline in the human foetoplacental unit.

Authors:  S Saarikoski
Journal:  Acta Physiol Scand Suppl       Date:  1974

4.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

Review 5.  A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines.

Authors:  U Trendelenburg
Journal:  Rev Physiol Biochem Pharmacol       Date:  1980       Impact factor: 5.545

6.  Characterization of the O-methylation of catechol oestrogens by intact rabbit thoracic aorta and subcellular fractions thereof.

Authors:  J J Reid; R E Stitzel; R J Head
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

7.  Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells).

Authors:  E Schömig; C L Schönfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

8.  Metabolism of 3H-dopamine by human chorioamnion in vitro.

Authors:  M Phillippe; J M Niloff
Journal:  Am J Obstet Gynecol       Date:  1982-08-01       Impact factor: 8.661

9.  The substrate specificity of uptake2 in the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

Review 10.  Fetal catecholamines.

Authors:  M Phillippe
Journal:  Am J Obstet Gynecol       Date:  1983-08-01       Impact factor: 8.661

View more
  1 in total

1.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Authors:  Martina Hayer-Zillgen; Michael Brüss; Heinz Bönisch
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.